Showing results (881-890 of 977) with videos related to

Sort By:
Pageof 98
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 14, 2020
Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) StudyNisha Bansal, Leila R Zelnick, Elsayed Z Soliman, et al.
International Journal of Cancer|December 11, 2023
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanismsLisa Dinter, Paula C Karitzky, Alexander Schulz, et al.
Cancer Research Communications|October 28, 2022
Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast CancerMargaret L Axelrod, Yu Wang, Yaomin Xu, et al.
Stroke|January 24, 2013
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapyW T Longstreth, Richard A Kronmal, John L P Thompson, et al.
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
Breast Cancer Research : BCR|November 26, 2024
Immune landscape of the tumour microenvironment in Ethiopian breast cancer patientsMeron Yohannes, Zelalem Desalegn, Marcus Bauer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 3, 2026
Multicentre validation of a patient-reported outcome measure for functional movement disordersRosa Michaelis, Leonie Hagedorn, Anne Weissbach, et al.
Pathogens (Basel, Switzerland)|January 21, 2022
Hepatitis E, Schistosomiasis and Echinococcosis-Prevalence in a Cohort of Pregnant Migrants in Germany and Their Influence on Fetal Growth RestrictionJanine Zöllkau, Juliane Ankert, Mathias W Pletz, et al.
Human Molecular Genetics|February 26, 2015
Molecular mechanism of CHRDL1-mediated X-linked megalocornea in humans and in Xenopus modelThorsten Pfirrmann, Denise Emmerich, Peter Ruokonen, et al.
Digestive Diseases and Sciences|February 3, 2018
Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with CirrhosisAyse L Mindikoglu, Antone R Opekun, William E Mitch, et al.
Pageof 98